Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From LivaNova PLC
Sofinnova Partners’ early-stage, "stay lean" approach to funding and incubating innovative medtech is unique in Europe, believes partner Anne Osdoit. She is seeking more investments for the company’s major MD Start III fund, while trying not to focus too much on thoughts of the next iteration.
While an mRNA vaccine is still missing, 2021 saw Indian companies strike alliances, battle legal action and gain funding while the regulator played a crucial enabling role in the run up to the approval of eight COVID-19 vaccines from zero in 2020.
Also, AstraZeneca presents more promising data for its COVID-19 antibody cocktail Evusheld and Novavax says its vaccine is able to neutralize the Omicron variant.
The market for surgical heart valve replacement devices is projected to steadily decline, as newer, more innovative transcatheter techniques poach customers, according to a new report from Informa’s Meddevicetracker.
- Implantable Devices
- Other Names / Subsidiaries
- Caisson Interventional, LLC
- CardiacAssist, Inc.
- Cyberonics, Inc., Ela Medical
- ImThera Medical, Inc.
- Sorin Group, Sorin S.p.A.
- Sulzer CarboMedics, Inc.